loading
前日終値:
$0.569
開ける:
$0.5757
24時間の取引高:
16,494
Relative Volume:
0.04
時価総額:
$19.27M
収益:
-
当期純損益:
$-98.79M
株価収益率:
-0.174
EPS:
-3.27
ネットキャッシュフロー:
$-51.66M
1週間 パフォーマンス:
-11.11%
1か月 パフォーマンス:
-9.68%
6か月 パフォーマンス:
+66.37%
1年 パフォーマンス:
-82.44%
1日の値動き範囲:
Value
$0.57
$0.5895
1週間の範囲:
Value
$0.5671
$0.6497
52週間の値動き範囲:
Value
$0.2404
$3.98

Relmada Therapeutics Inc Stock (RLMD) Company Profile

Name
名前
Relmada Therapeutics Inc
Name
セクター
Healthcare (1168)
Name
電話
646 876 3459
Name
住所
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, NY
Name
職員
17
Name
Twitter
@relmada
Name
次回の収益日
2025-03-25
Name
最新のSEC提出書
Name
RLMD's Discussions on Twitter

RLMD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
3.03 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.72 835.81M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.52 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
2.65 121.87M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1546 313.13M 2.07B -1.42B -1.37B -0.6765
 icon
DAVEW
Dave Inc
1.35 0 0 0 0 0.00

Relmada Therapeutics Inc Stock (RLMD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-05 ダウングレード Mizuho Outperform → Neutral
2024-09-17 アップグレード Jefferies Hold → Buy
2024-06-05 ダウングレード Goldman Neutral → Sell
2022-10-14 ダウングレード Goldman Buy → Neutral
2022-10-14 ダウングレード Guggenheim Buy → Neutral
2022-10-14 ダウングレード Truist Buy → Hold
2022-10-13 ダウングレード Oppenheimer Outperform → Perform
2021-11-18 開始されました Mizuho Buy
2021-05-20 再開されました Goldman Buy
2020-10-28 ダウングレード Goldman Buy → Neutral
2020-07-14 開始されました Oppenheimer Outperform
2020-05-04 開始されました SunTrust Buy
2020-04-21 開始されました Goldman Buy
2020-01-27 開始されました Jefferies Buy
2020-01-10 開始されました SVB Leerink Outperform
2019-12-16 開始されました Guggenheim Buy
すべてを表示

Relmada Therapeutics Inc (RLMD) 最新ニュース

pulisher
07:56 AM

Advanced analytics toolkit walkthrough for Relmada Therapeutics Inc.Real Time Alert System for Market Moves - Newser

07:56 AM
pulisher
12:58 PM

Is a relief rally coming for Relmada Therapeutics Inc. holdersSafe Entry Zone Based on Chart Analysis - Newser

12:58 PM
pulisher
Aug 05, 2025

Using fundamentals and technicals on Relmada Therapeutics Inc.Reversal Signal Prediction Based on Volume - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

What makes Relmada Therapeutics Inc. stock price move sharplyROI Focused Setup Screener With Exit Markers - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

How to monitor Relmada Therapeutics Inc. with trend dashboardsSmart Swing Picks with Confirmed Signals - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

What’s next for Relmada Therapeutics Inc. stock priceFree Early Entry Tips With Low Risk Zone - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

Published on: 2025-08-04 12:29:06 - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Will a bounce in Relmada Therapeutics Inc. offer an exitWeekly Setup Summary for Risk Controlled Trades - Newser

Aug 04, 2025
pulisher
Aug 04, 2025

What are the latest earnings results for Relmada Therapeutics Inc.Get alerts on top growth stocks daily - Jammu Links News

Aug 04, 2025
pulisher
Aug 04, 2025

Why Relmada Therapeutics Inc. stock attracts strong analyst attentionFree Alert Feed for Momentum Based Picks - Newser

Aug 04, 2025
pulisher
Aug 03, 2025

Using portfolio simulators with Relmada Therapeutics Inc. includedShort-Term Stock Trend Forecast Guide - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Relmada Therapeutics Inc. stock higher in 2025Unlock powerful trading signals for profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Relmada Therapeutics Inc. stock compared to the marketRobust investment performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Relmada Therapeutics Inc. compare to its industry peersBuild a diversified portfolio for steady growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Relmada Therapeutics Inc. stockInvest in stocks with strong fundamentals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Relmada Therapeutics Inc. stockInvest in stocks with long-term growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Relmada Therapeutics Inc. stock priceCapitalize on emerging market opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Real time breakdown of Relmada Therapeutics Inc. stock performanceOversold Reversal Picks with Buy Zone - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Relmada Therapeutics Inc. stockAccess daily stock market expert updates - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Relmada Therapeutics Inc. in the next 12 monthsUnbelievable profit margins - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

How strong is Relmada Therapeutics Inc. company’s balance sheetInvest in stocks with strong fundamentals - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Why is Relmada Therapeutics Inc. stock attracting strong analyst attentionStay informed with daily expert analysis - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are Relmada Therapeutics Inc. company’s key revenue driversStay informed with daily expert analysis - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Relmada Therapeutics (RLMD.US) will release its earnings reports after the market closes on August 7th. - 富途牛牛

Aug 01, 2025
pulisher
Jul 31, 2025

Building trade automation scripts for Relmada Therapeutics Inc.Free Safe Entry Stock Watch Suggestions - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - The Manila Times

Jul 31, 2025
pulisher
Jul 31, 2025

Relmada Therapeutics Sets Q2 Earnings Date: Key Updates Expected on Oncology and CNS Pipeline - Stock Titan

Jul 31, 2025
pulisher
Jul 30, 2025

Relmada Therapeutics Inc. At Decision Level — Rebound or ResistanceReal Time Stock Movement Analysis Indicates Breakout - beatles.ru

Jul 30, 2025
pulisher
Jul 30, 2025

Relmada Therapeutics (NASDAQ:RLMD) Shares Down 2.3% – Here’s What Happened - Defense World

Jul 30, 2025
pulisher
Jul 28, 2025

Does Relmada Therapeutics Inc. stock perform well during market downturnsBeginner Investor Growth Plan For Every Investor - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

When is Relmada Therapeutics Inc. stock expected to show significant growthPost Market Outlook For Every Investor - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

Why Relmada Therapeutics Inc. stock attracts strong analyst attention Monthly Trade Result and Signal Summary - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Why Relmada Therapeutics Inc. stock attracts strong analyst attention AI Screener Based Stock Summary Report - metal.it

Jul 28, 2025

Relmada Therapeutics Inc (RLMD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Relmada Therapeutics Inc (RLMD) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Shenouda Maged
Chief Financial Officer
May 19 '25
Buy
0.49
90,000
43,686
228,335
Shenouda Maged
Chief Financial Officer
May 20 '25
Buy
0.52
60,000
31,422
288,335
Shenouda Maged
Chief Financial Officer
May 16 '25
Buy
0.44
50,000
22,100
138,335
Ence Chuck
CA and CO
May 16 '25
Buy
0.45
228,961
103,330
267,931
TRAVERSA SERGIO
Chief Executive Officer
May 20 '25
Buy
0.56
147,686
82,246
734,024
TRAVERSA SERGIO
Chief Executive Officer
May 16 '25
Buy
0.45
172,314
77,472
556,338
TRAVERSA SERGIO
Chief Executive Officer
May 19 '25
Buy
0.50
30,000
14,994
586,338
TRAVERSA SERGIO
Chief Executive Officer
Sep 11 '24
Buy
2.99
51,407
153,707
384,024
TRAVERSA SERGIO
Chief Executive Officer
Sep 09 '24
Buy
2.71
55,579
150,619
299,603
TRAVERSA SERGIO
Chief Executive Officer
Sep 10 '24
Buy
2.75
33,014
90,788
332,617
$76.89
price down icon 1.05%
$37.03
price down icon 2.70%
$110.91
price down icon 0.71%
$28.69
price down icon 1.65%
$110.22
price down icon 0.82%
biotechnology ONC
$292.39
price down icon 4.91%
大文字化:     |  ボリューム (24 時間):